South America Diabetic Foot Ulcer Treatment Market
No. of Pages: 158 | Report Code: TIPRE00024697 | Category: Life Sciences
No. of Pages: 158 | Report Code: TIPRE00024697 | Category: Life Sciences
SAM consists of two major countries namely Argentina and Brazil. The market is also evaluated for the Rest of SAM market. The region holds significant portion of the diabetic foot ulcer treatment market at a global level. Brazil dominate the market. Brazil is among the largest economy in the South and Central American region. The healthcare facilities and services are offered broadly as compared to the countries in the region. In previous years due to economic crises, Brazil has faced several challenges. However, the changing scenarios and development in the healthcare industry have led to the growth of various market players in wound care business. Moreover, in Brazil, the cases of wounds are increasing; the rising prevalence of diabetes is leading to the growing numbers for foot ulcers. According to International Diabetes Federation data, Brazil has 12.5 million adults diagnosed with diabetes. This represents the fourth largest in country population in the world and approximately 9% of the adult population. Reliable local studies indicate that 7% of diabetic adults develop diabetic foot ulcers, so the current DFU patient population in Brazil stands at approximately 900,000. Currently there are no effective curative treatments for DFUs being utilized in the country, which has led to high rates of lower limb amputations. Increasing prevalence of diabetes and related chronic wounds and use of 3D printing in wound care management are the major factor driving the growth of the SAM diabetic foot ulcer treatment market.
In case of COVID-19, SAM is highly affected especially Brazil. Many SAM countries have faced shortages of resources to manufacture and supply medical products. Some of the hard-hit countries such as Brazil, where case number surpassed 13,601,566, and Argentina, the case recorded as 2,579,000 as of May 2021. It is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the area. COVID-19 continues to have a tremendous impact on the region. Although Peru established one of the strictest lockdowns in the SAM region, it suffered the highest mortality rate due to COVID-19. The coronavirus pandemic has become an enormous challenge to this region, as they are low-cost regions. Over the past few months, the region has implemented telehealth strategies. For instance, in March 2020, Brazilian Ministry of health recommended telemedicine as medical practice for wound and injury care, education and health promotion purposes. The Centro de Referência Estadual para a Assistência ao Diabetes e Endocrinologia (CEDEBA) located in Salvador, Bahia in Brazil have created a structured screening system for patients who need care for diabetic foot ulcer treatment. These factors are expected support market for diabetic foot ulcer treatment market in this region. However, in 2021, vaccination was made available in the region, due to which the number of infected persons is expected to come down, thereby boosting the economy and helping the wound care industry to recover in this region.
Strategic insights for the South America Diabetic Foot Ulcer Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 243.21 Million |
| Market Size by 2028 | US$ 385.79 Million |
| Global CAGR (2021 - 2028) | 6.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South America Diabetic Foot Ulcer Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The SAM diabetic foot ulcer treatment market is expected to grow from US$ 243.21 million in 2021 to US$ 385.79 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. Rise in the geriatric population is expected to escalate the market growth. The elderly population is defined as a group of people aged 65 and over. Aging is poised to BE one of the most significant social transformations of the 21st century. The aging population is significantly observed issue in the SAM region. For instance, as per the Statistics, more than 20.3% of the population belonged to the age group of 65 and above in 2019, and this number is expected to reach a significant high by 2050. Older adults are more likely to be diabetic and are further likely to develop diabetic foot ulcers, and the chronic wounds are likely to have a severe effect on the quality of life of this group of population. The wound healing process is more prolonged in the aging population due to the basic biology underlying chronic wounds and age-associated changes in wound healing. Therefore, with the growing elderly population, the demand of advanced diabetic foot ulcer treatments would continue to increase in the coming years, which will drive the SAM market in coming years.
In terms of type, the advanced wound care dressings segment accounted for the largest share of the SAM diabetic foot ulcer treatment market in 2020. In terms of ulcer type, the neuro-ischemic ulcers segment held a larger market share of the SAM diabetic foot ulcer treatment market in 2020. Further, the hospitals segment held a larger share of the SAM diabetic foot ulcer treatment market based on end user in 2020.
A few major primary and secondary sources referred to for preparing this report on the SAM diabetic foot ulcer treatment market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Medline Industries, Inc.; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO.
The South America Diabetic Foot Ulcer Treatment Market is valued at US$ 243.21 Million in 2021, it is projected to reach US$ 385.79 Million by 2028.
As per our report South America Diabetic Foot Ulcer Treatment Market, the market size is valued at US$ 243.21 Million in 2021, projecting it to reach US$ 385.79 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The South America Diabetic Foot Ulcer Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Diabetic Foot Ulcer Treatment Market report:
The South America Diabetic Foot Ulcer Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Diabetic Foot Ulcer Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Diabetic Foot Ulcer Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Diabetic Foot Ulcer Treatment Market
